Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects

DNA and Cell Biology

Volumn 24, Issue 7, 2005, Pages 410-431

  Prabhakar, Uma ^a   Conway, Theresa M ^b   Murdock, Paul ^b   Mooney, Jeff L ^b   Clark, Steve ^b   Hedge, Priti ^b   Bond, Brian C ^b   Jazwinska, Elizabeth C ^d   Barnes, Michael R ^b   Tobin, Frank ^b   Damian Iordachi, Valeriu ^b   Greller, Larry ^b   Hurle, Mark ^b   Stubbs, Andrew P ^b   Li, Zhong ^b   Valoret, Elizabeth I ^c   Erickson Miller, Connie ^c   Cass, Lisa ^b   Levitt, Blanche ^b   Davis, Hugh M ^a   Jorkasky, Diane K ^c   Williams, William V ^e   more..

^a CENTOCOR INC   (United States)

^b GLAXOSMITHKLINE   (United States)

^c PFIZER INC   (United States)

^d Johnson Research   (Australia)

^e Drug Metabolism Pharmacokinetics Clinical Pharmacology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; ENDOTOXIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA MICROARRAY; ENDOTOXEMIA; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; CYTOKINES; ENDOTOXINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; INJECTIONS, INTRAVENOUS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; KINETICS; MALE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PROTEINS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 22244471988     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.410     Document Type: Article

References (52)

1. BAUMGARTNER, J.-D., GLAUSER, M.P., and MCCUTCHAN, J.A. (1985). Prevention of Gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet 2, 59-63.
2. BUDNIK, A., GREWER, M., GYUFKO, K., and KRUTMANN, J. (1996). Analysis of the production of soluble ICAM-1 molecules by human cells. Exp. Hematol. 24, 352-359.
3. BURRELL, R. (1990). Immunomodulation by bacterial endotoxin. Microbiology 17, 189-208.
4. BURRELL, R. (1994). Human responses to bacterial endotoxin. Circ. Shock 43, 137-153.
5. DANNER, R.L., ELIN, R.J., HOSSEINI, J.M., WESLEY, R.A., and PARRILLO, J.E. (1991). Endotoxemia in human septic shock. Chest 99, 169.
6. DEFORCE, L.E., NGUYEN, D.T., KUNKEL, S.L., and REMICK, D.G. (1990). Regulation of the pathophysiology of tumor necrosis factor. J. Lab. Clin. Med. 116, 429-438.
7. DELA CADENA, R.A., MAJLUF-CRUZ, A., STADNICKI, A., AGOSTI, J.M., COLMAN, R.W., and SUFFREDINI, A.F. (1996). Activation of the contact and fibrinolytic systems after intravenous administration of endotoxin to normal human volunteers: Correlation with the cytokine profile. Immunopharmacology 33, 231-237.
8. ELIN, R.J., WOLFF, S.M., MCADAM, K.P.W.J., CHEDID, L., AUDIBERT, F., BERNARD, C., and OBERLING. F. (1981). Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. J. Infect. Disc. 144, 329-336.
9. ENGLEHARDT, R., MACKENSEN, A., GALANOS, C., and ANDRESEN, R. (1990). Biological response to intravenously administered endotoxin in patients with advanced cancer. J. Biol. Response Mod. 9, 480-491.
10. FONG, Y., MOLDAWER, L.L., and MORANO, M. (1989a). Endotoxemia elicits increased circulating beta-IFN/IF-6 in man. J. Immunol. 142, 2321-2324.
11. FONG, Y., TRACEY, K.J., and MOLDAWER, L.L. (1989b). Antibodies to cachectin/tumor necrosis factor reduce interleukin 1b and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 84, 1627-1633.
12. FONG, Y., MARANO, M.A., and MOLDAWER, L.L. (1990). The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J. Clin. Invest. 85, 1896-1904.
13. GALLEY, H.F., BLAYLOCK, M.G., DUBBELS, A.M., and WEBSTER, N.R. (2000). Variability in E-selectin expression, mRNA levels and sE-selectin release between endothelial cell lines and primary endothelial cells. Cell Biol. Int. 24, 91-99.
14. GRANOWITZ, E.V., SANTOS, A.A., POUSIAKA, D.D., CANNON, J.G., WILMORE, D.W., WOLFF, S.M., and DINARELLO, C.A. (1991). Production of interleukin-1 receptor antagonist during experimental endotoxemia. Lancet 1, 1423-1424.
15. HELLER, R.A., SCHENA, M., CHAI, A., SHALON, D., BEDILION, T., GILMORE, J., WOOLLEY, D.E., and DAVIS, R.W. (1997). Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc. Natl. Acad. Sci. USA 94, 2150-2155.
16. HESSE, D.G., TRACEY, K.J., and FONG, Y. (1988). Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166, 147-153.
17. JIA, S.H., LI, Y., PARODO, J., KAPUS, A., FAN, L., ROTSTEIN, O.D., and MARSHALL, J.C. (2004). Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J. Clin. Invest. 113, 1318-1326
18. [Erratum in J. Clin. Invest. 114, 141 (2004)].
19. JOHNSON, J.A. (2004). Are SOCS suppressors, regulators, and degraders? J. Leukoc. Biol. 75, 734-748.
20. KREGER, B.E., CRAVEN, D.E., and MCCABE, W.R. (1980). Gram-negative bacteremia, IV. Re-evaluation of clinical features and treatment in 612 patients. Am. J. Med. 68, 344-355.
21. KUHNS, D.B., ALVORD, W.G., and GALLIN, J.I. (1995). Increased circulating cytokines, cytokine antagonist, and E-selectin after intravenous administration of endotoxin in humans. J. Infect. Dis. 171, 145-152.
22. KUSHNER, I. (1982). The phenomenon of the acute phase response. Ann. N.Y. Acad. Sci. 389, 39-48.
23. LANG, R., and HEEG, K. (1998). Semiquantitative determination of human cytokine mRNA expression using TaqMan RT-PCR. Inflammopharmacology 6, 297-309.
24. LECA, G., MANSUR, S.E., and BENSUSSAN, A. (1995). Expression of VCAM-1 (CD106) by a subset of TCR gamma delta-bearing lymphocyte clones. Involvement of a metalloprotease in the specific hydrolytic release of the soluble isoform. J. Immunol. 154, 1069-1077.
25. LENNON, G., AUFFRAY, C., POLYMEROPOLOUS, M., and SOARES, M.B. (1996). The I.M.A.G.E. consortium: An integrated molecular analysis of genomes and their expression. Genomics 33, 151-152.
26. LEUTENEGGER, C.M., MISLIN, C.N., SIGRIST, B., EHRENGRUBER, M.U., HOFMANN-LEHMANN, R., and LUTZ, H. (1999). Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet. Immunol. Immunopathol. 71, 291-305.
27. LYONS, P.D., and BENVENISTE, E.N. (1998). Cleavage of membrane-associated ICAM-1 from astrocytes: Involvement of a metalloprotease. Glia 22, 103-112.
28. MARTICH, G.D., DANNER, R.L., CESKA, M., and SUFFREDINI, A.F. (1991). Detection of interleukin-8 and tumor necrosis factor in normal humans after intravenous endotoxin - The effect of anti-inflammatory agents. J. Exp. Med. 173, 1021-1024.
29. MICHIE, H.R., KIRK, M.B., MONOGUE, R., SPRIGGS, D.R., REVHAUG, A., O'DWYER, S., DINARELLO, C.A., CERAMI, A., WOLFF, S.M., and WILMORE, D.W. (1988a). Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318, 1481-1486.
30. MICHIE, H.R., SPRIGGS, D.R., and MANOGUE, K.R. (1988b). Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104, 280-286.
31. MOONEY, J.L., KAYNE, P.S., O'BRIEN, S.P., and DEBOUCK, C. (2000). Construction and applications of gene microarrays on nylon membranes. In Differential Display: A Practical Approach. R.A. Leslie and H.A. Robertson, eds. (Oxford University Press, Oxford).
32. MORITA, M., WATANABE, Y., and AKAIKE, T. (1994). Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology 19, 426-131.
33. OPPENHEIM, J.J., ZACHARIAE, C.O.C., MUKAIDA, N., and MATSUSHIMA, K. (1991). Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9, 617-648.
34. PARKER, M.M., SHELHAMER, J.H., NATANSON, C., ALLING, D.W., and PARRILLO, J.E. (1987). Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis. Crit. Care Med. 15, 923-929.
35. PARRILLO, J.E. (1993). Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328, 1471-1477.
36. PARRILLO, J.E., PARKER, M.M., NATANSON, C., SUFFREDINI, A.F., DANNER, R.L., CUNNION, R.E., and OGNIBENE, F.P. (1990). Septic shock in humans: Advances in the understanding of pathogenesis. Cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113, 227.
37. RICHARDSON, R.P., RHYNE, C.D., FONG, Y., HESSE, D.G., TRACEY, K.J., MARANO, M.A., LOWRY, S.F., ANTONACCI, A.C., and CALVANO, S.E. (1989). Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Ann. Surg. 210, 239-245.
38. SCHENA, M., SHALON, D., HELLER, R.A., CHAI, A., BROWN, P.O., and DAVIS, R.W. (1996). Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. USA 93, 10614-10619.
39. SCHREIBER, W., POLLMACHER, T., FASSBENDER, K., GUDEWILL, S., BEDDER, H., WIEDEMANN, K., GALANOS, C., and HOLSBOER, F. (1993). Endotoxin-releasing and corticotropin-releasing hormone-induced release of ACTH and cortisol - A comparative study in men. Neuroendocrinology 58, 123-128.
40. SHALON, D., SMITH, S.J., and BROWN, P.O. (1996). A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 6, 639-645.
41. SHARIPIRO, L., CLARK, B.D., ORENCOLE, S.F., POYSIAKA, D.D., GRANOWITZ, E.V., and DINARELLO, C.A. (1993). Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J. Infect. Dis. 167, 1344-1350.
42. SUFFREDINI, A.F., HARPEL, P.C., and PARRILLO, J.E. (1989). Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N. Engl. J. Med. 320, 1165-1172.
43. SUFFREDINI, A.F., REDA, D., BANKS, S.M., TROPEA, M., AGOSTI, J.M., and MILLER, R. (1995). Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J. Immunol. 155, 5038-5045.
44. TEAGUE, T.K., HILDEMAN, D., KREDL, R.M., MITCHELL, T., REES, W., SCHAEFER, B.C., BENDER, J., KAPPLER, J., and MARRACK, P. (1999). Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl. Acad. Sci. USA 96, 12691-12696.
45. VAN DER POLL, T., VAN DEVENTER, S.J.H., BULLER, H.R., STURK, A., and TEN GATE, J.W. (1991). Comparison of the early dynamics of coagulation activation after injection of endotoxin and tumor necrosis factor in healthy humans. Bacterial endotoxins: Cytokine mediators and new therapies for sepsis. Prog. Clin. Biol. Res. 367, 55-60.
46. VAN DER POLL, T., GALVANO, S.E., KUMAR, S., BRAXTON, C.C., COYLE, S.M., BARBOSA, K., MOLDAWER, L.L., and LOWRY, S.F. (1995). Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans. Blood 86, 2754-2759.
47. VAN DEVENTER, S.J.H., BULLER, H.R., TEN GATE, J.W., STURK, A., and PAUW, W. (1988). Endotoxaemia: An early predictor of septicaemia in febrile patients. Lancet 1, 605-609.
48. VAN DEVENTER, S.J.H., BULLER, H.R., TEN GATE, J.W., AARDEN, L.A., HACK, C.E., and STURK, A. (1990). Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 76, 2520.
49. WANG, S., LI, X., CURRIE, W., WILLETTE, R.N., BARONE, F.C., and FEUERSTEIN, G.Z. (2000). Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance. J. Neurosci. Res. 59, 238-246.
50. WATANABE, Y., MORITA, M., IKEMATSU, N., and AKAIKE, T. (1995). Tumor necrosis factor alpha and interleukin-1 beta but not interferon gamma induce vascular cell adhesion molecule-1 expression on primary cultured murine hepatocytes. Biochem. Biophys. Res. Commun. 209, 335-342.
51. WILLIAMS, L.M., GIBBONS, D.L., GEARING, A., MAINI, R.N., FELDMANN, M., and BRENNAN, F.M. (1996). Paradoxical effects of a synthetic metalloprotease inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures. J. Clin. Invest. 97, 2833-2841.
52. ZIEGLER, E.J., MCCUTCHAN, J.A., and FIERER, J. (1982). Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N. Engl. J. Med. 307, 1225-1230.